Key facts
- This page summarizes Nicholas Plummer's Form 4 filing for VOLITIONRX LTD (VNRX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Nov 2021, 16:07.
Nicholas Plummer - 01 Nov 2021 Form 4 Insider Report for VOLITIONRX LTD (VNRX)
- Reporting relationship
- GC - Volition Diagnostics
- Issuer ticker
- VNRX
- Reported as of
- 01 Nov 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Nov 2021, 16:07:53 UTC
- Next SEC filing
- 14 Oct 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nicholas Plummer
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Nicholas Plummer filed Form 4 for VOLITIONRX LTD (VNRX) on 03 Nov 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VNRX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +43,500
- Change %
- Price
- $0.000000
- Shares after
- 43,500
- Date
- 01 Nov 2021
- Ownership
- Direct
- Footnotes
- F1
VNRX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,500
- Date
- 01 Nov 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
In connection with his employment as General Counsel of Volition Diagnostics UK Limited, Mr. Plummer received restricted stock units subject to a 2-year vesting schedule, vesting as to 21,750 units on each of 11/01/22 and 11/01/23, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.